STOCKHOLM (MedPage Today) — Tighter safety standards for approval of diabetes drugs are coming to Europe with the cautious support of the European Association for the Study of Diabetes.
No Comments »
Filed under: General Health News
(MedPage Today) — SILVER SPRING, Md. — An FDA advisory panel has voted unanimously to recommend approval of the investigational anticoagulant dabigatran to reduce the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation.
No Comments »
Filed under: General Health News
ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and [...]
No Comments »
Filed under: Pharmacy News
The University of Maryland School of Pharmacy has received a prestigious $3.7 million grant to develop a drug to treat cocaine addiction based on an active ingredient found in some Chinese prescription medicines.
No Comments »
Filed under: Pharmacy News
VIVUS, Inc. today announced positive top-line results from a two-year study of QNEXA(phentermine/topiramate) Controlled Release Capsules, an investigational therapy for treatment of obesity, a condition that affects approximately one-third of adult Americans.
No Comments »
Filed under: Pharmacy News
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 [...]
No Comments »
Filed under: Pharmacy News
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen’s product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and [...]
No Comments »
Filed under: Pharmacy News
Data from the GRACE study will be published in the September 21st issue of the Annals of Internal Medicine. GRACE is the largest-ever study of treatment experienced adult women with HIV-1 to examine gender differences in response to HIV therapy. Sponsored by Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech Services, LLC, the [...]
No Comments »
Filed under: Pharmacy News
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in [...]
No Comments »
Filed under: Pharmacy News
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio’s PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted [...]
No Comments »
Filed under: Pharmacy News
